Liver Document - Treatments

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/84

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

85 Terms

1
New cards

What are the main reasons to use glucocorticoids in hepatobiliary disease?

Anti-inflammatory, anti-fibrotic, cholerectic effects, appetite stimulation, and reduction of copper absorption.

2
New cards

In which diseases are glucocorticoids indicated?

Chronic hepatitis, cholangitis, or cholangiohepatitis with lymphoplasmacytic inflammation.

3
New cards

Why are glucocorticoids contraindicated in infectious hepatitis?

They suppress immunity, allowing infection to worsen.

4
New cards

Why are glucocorticoids not recommended for acute hepatitis?

They have been linked to increased mortality; most acute liver injuries recover with supportive therapy alone.

5
New cards

What complication can glucocorticoids cause in dogs with portal hypertension?

Exacerbation of GI ulceration and worsening of portal hypertension.

6
New cards

What are the potential metabolic side effects of glucocorticoids?

Muscle catabolism, weakness, polyuria/polydipsia, immunosuppression.

7
New cards

Why is prednisolone preferred over prednisone in cats?

Cats have limited hepatic ability to convert prednisone to prednisolone.

8
New cards

What is the typical prednisolone dose for chronic hepatitis in dogs?

1–2.2 mg/kg/day (max 60 mg/day), tapered after improvement.

9
New cards

Which glucocorticoid offers more localized hepatic action and fewer systemic effects?

Budesonide — undergoes extensive first-pass hepatic metabolism.

10
New cards

What is a key precaution when using budesonide?

 It can still suppress the HPA axis despite lower systemic absorption.

11
New cards

What are alternatives to glucocorticoids in chronic hepatitis or steroid-refractory cases?

Azathioprine, mycophenolate mofetil, cyclosporine, chlorambucil, and leflunomide.

12
New cards

Which drug is preferred for chronic hepatitis in dogs with immune-mediated etiology?

Cyclosporine (≈50% remission rate).

13
New cards

Why is azathioprine generally avoided in cats?

Causes severe bone marrow suppression.

14
New cards

Which immunosuppressant can cause hepatotoxicity in dogs?

Azathioprine.

15
New cards

What are common adverse effects across immunosuppressants?

GI upset, hepatotoxicity, pancreatitis, and bone marrow suppression.

16
New cards

What monitoring is recommended during immunosuppressive therapy?

Periodic CBC, liver enzymes, and drug level monitoring (especially cyclosporine).

17
New cards

What is the mechanism of ursodeoxycholic acid (ursodiol)?

Hydrophilic bile acid that replaces toxic hydrophobic bile acids, stimulates bile flow, and protects hepatocytes.

18
New cards

What are other benefits of ursodiol?

Anti-apoptotic, antioxidant, and membrane-stabilizing effects.

19
New cards

What is the dose of ursodiol?

15 mg/kg/day, divided (BID dosing preferred for steady flow).

20
New cards

Why should ursodiol be given with food?

It’s fat-soluble, enhancing absorption.

21
New cards

When is ursodiol contraindicated?

Biliary obstruction, since increased bile flow can cause rupture.

22
New cards

Which antioxidant may have mild cholerectic properties?

SAMe, via increased glutathione synthesis.

23
New cards

What is the mechanism of colchicine in liver disease?

Inhibits microtubule assembly, increasing collagenase activity and decreasing fibrosis.

24
New cards

When is colchicine used?

For chronic fibrotic liver disease or amyloidosis.

25
New cards

What is the main adverse effect of colchicine?

Gastrointestinal upset (vomiting, diarrhea).

26
New cards

What is the typical dose of colchicine for dogs?

0.03 mg/kg/day.

27
New cards

True or False? There is little evidence of the efficacy of colchicine.

True.

28
New cards

What are other drugs that may have mild anti-fibrotic effects?

Glucocorticoids, SAMe, silymarin, vitamin E, azathioprine, zinc, penicillamine, and possibly losartan (angiotensin blocker).

29
New cards

Name common antioxidants used in hepatobiliary disease

Vitamin E, SAMe, silymarin/silybin, zinc, curcumin, NAC, and ursodiol.

30
New cards

What is the general role of antioxidants in hepatic therapy?

Reduce oxidative injury, stabilize membranes, and support hepatocellular regeneration.

31
New cards

What is the role of vitamin E?

Protects against lipid peroxidation in membranes; water-soluble forms are better in cholestatic disease.

32
New cards

Vitamin E dose for dogs?

10 IU/kg/day (as d-alpha tocopherol).

33
New cards

What is SAMe (S-adenosyl-L-methionine)?

A methyl donor and precursor of cysteine/glutathione for detoxification and antioxidation.

34
New cards

What happens to SAMe levels in liver disease?

Decrease due to reduced synthesis and SAMe-synthase activity.

35
New cards

SAMe dose for dogs?

20 mg/kg/day.

36
New cards

What are the veterinary SAMe formulations?

Denosyl® (SAMe alone), Denamarin® (SAMe + silybin), and Marin® (silybin + vitamin E + zinc).

37
New cards

What is silymarin/silybin, and what is its role?

Extract from milk thistle; increases superoxide dismutase, protects against oxidative and toxin-induced hepatic injury.

38
New cards

What is the typical silybin dose?

5 mg/kg (50–250 mg BID).

39
New cards

What toxicities has silybin been shown to protect against?

Acetaminophen and Amanita mushroom poisoning.

40
New cards

What is N-acetylcysteine (NAC) used for?

Replenishes glutathione, improves hepatic blood flow, and protects against ischemia-reperfusion injury.

41
New cards

How can NAC be administered?

IV (140 mg/kg loading, then 50–70 mg/kg × 7 doses) or PO (50–70 mg/kg TID).

42
New cards

When is NAC especially useful?

In hospitalized patients with acute hepatopathies unable to take oral meds.

43
New cards

True or False? Anti-oxidants such as vitamin E, s-adenyl-L-methione (SAMe), silymarin/silybin, zinc, curcumin, N-acetylcysteine and UDA has lots of peer-reviewed evidence to support its treatment of naturally occurring liver disease in dogs and cats.

False. There is little peer-reviewed evidence to support the use of antioxidants to treat naturally occurring liver disease in dogs and cats.

44
New cards

When are copper chelators indicated?

When hepatic copper > 1000 ppm (toxic accumulation).

45
New cards

What is the first-line chelator for copper-associated hepatitis?

D-penicillamine

46
New cards

What is the D-penicillamine dose?

10–15 mg/kg BID with meals.

47
New cards

What is the mechanism of copper chelators?

Bind extracellular copper → increase urinary excretion → draw intracellular copper outward.

48
New cards

What are side effects of D-penicillamine?

Vomiting, anorexia, and reactions similar to penicillin hypersensitivity.

49
New cards

What other chelators exist but are less available?

2,2,2-tetramine and tetrathiomolybdate.

50
New cards

What mineral supplement reduces copper absorption?

 Zinc (zinc gluconate or acetate).

51
New cards

How does zinc reduce copper absorption?

Induces intestinal metallothionein, which binds and sequesters copper in enterocytes.

52
New cards

When should zinc be given relative to food?

1 hour before meals (food reduces absorption).

53
New cards

Why should chelators and zinc not be given together?

Chelators bind zinc, reducing efficacy of both.

54
New cards

How long is chelation therapy given for?

3–8 months depending on copper level:
- Mild (1,000–1,500 ppm): 3–4 mo
- Moderate (1,500–2,500 ppm): 4–6 mo
- Severe (> 3,000 ppm): 6–8 mo.

55
New cards

What follow-up is recommended after chelation?

Recheck liver enzymes or repeat biopsy for copper quantification.

56
New cards

When copper levels normalize, what maintenance is used?

Low-copper diet ± low-dose chelator or zinc supplement.

57
New cards

What is the goal of diet therapy in HE, hepatic encephalopathy?

Reduce ammonia production while maintaining adequate protein for repair.

58
New cards

What protein level is recommended for dogs without HE?

~60 g/1000 kcal (normal hepatic diet).

59
New cards

What protein level for dogs with HE?

45–50 g/1000 kcal (reduced protein).

60
New cards

What protein sources are preferred in HE diets?

Eggs, dairy, and soy (less ammoniagenic).

61
New cards

What is the main pharmacologic agent for HE?

Lactulose (reduces intestinal ammonia absorption).

62
New cards

What is the oral dose of lactulose?

0.25 mL/kg PO 2–3 × daily; adjust to produce soft stools.

63
New cards

What is the IV or enema form of lactulose used for?

Moribund or comatose patients unable to take oral medication.

64
New cards

What antibiotics can reduce ammonia-producing bacteria?

Metronidazole, ampicillin, or neomycin (though metronidazole is most common).

65
New cards

What is a recent recommendation regarding chronic antibiotics for HE?

Not always necessary; lactulose + diet may suffice.

66
New cards

Why is hydration critical in HE?

Prevents ammonia concentration buildup and renal hypoperfusion.

67
New cards

What dietary modification helps manage ascites from PH, portal hypertension?

Sodium restriction (low-sodium liver diets).

68
New cards

What is the preferred diuretic for chronic ascites in PH?

Spironolactone (aldosterone receptor antagonist).

69
New cards

When might a loop diuretic (furosemide) be added?

In acute exacerbations, alongside spironolactone, then tapered off.

70
New cards

Why is spironolactone preferred over furosemide long-term?

It spares potassium and reduces RAAS activation.

71
New cards

What can worsen PH and HE if fluid is removed too aggressively?

RAAS activation → sodium retention → worsening ascites and hypokalemia.

72
New cards

What is the role of IV fluids in PH management?

Correct dehydration, improve renal perfusion, and reduce RAAS drive.

73
New cards

Why are dogs and cats with portal hypertension predisposed to ulcers?

Gut ischemia from venous congestion.

74
New cards

Why is sucralfate (Carafate) often ineffective for proximal GI ulcers in these patients?

It acts locally and poorly adheres to mucosa under bile conditions.

75
New cards

Which acid suppressant is preferred?

Omeprazole (proton pump inhibitor).

76
New cards

What is a risk of long-term PPI use?

Alters gut microbiota and may worsen HE.

77
New cards

Why should PPIs be tapered slowly when discontinued?

To avoid rebound hypergastrinemia and acid rebound.

78
New cards

What other GI drugs can support hepatic patients?

Antiemetics such as serotonin inhibitors (ondansetron) or NK-1 antagonists (maropitant).

79
New cards

Drugs to use for inflammatory hepatitis:

Immunosuppression ± glucocorticoid.

80
New cards

Drugs to use for cholestatic disease:

Ursodiol, SAMe, antioxidants.

81
New cards

Drugs to use for fibrosis:

Colchicine, anti-fibrotics, antioxidants.

82
New cards

Drugs to use for copper storage disease:

Chelators, zinc, low-copper diet.

83
New cards

Drugs to use for encephalopathy:

Lactulose, protein-modified diet, metronidazole.

84
New cards

Drugs to use for portal hypertension

Spironolactone, sodium restriction.

85
New cards